A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis
Identification
- Public canonical key
- radar:r-b1124e532cd3733b5ba9578ff074ab7c
- Authors
- Arduino Aleksander Mangoni · Michael David Wiese · Richard John Woodman · Salvatore Sotgia · Angelo Zinellu · Ciriaco Carru · Julie-Ann Hulin · Ernst Michael Shanahan · Sara Tommasi
- Reported year
- 2025
- Reported language
- en
- Source type
- article
- First detected
- 2026-11-13T12:42:57.722431+00:00
- Last metadata observation
- 2026-11-13T12:42:57.722431+00:00
- Last HTTP verification
- Not checked
Institutions reported by the source
Flinders University · SA Health · University of South Australia · University of Sassari · Azienda Ospedaliero Universitaria di Sassari · Flinders Medical Centre
Reported affiliation countries
AU · IT
Documentary abstract — original language
Introduction Observational studies have shown that methotrexate, a conventional synthetic disease-modifying antirheumatic drug (csDMARD), is associated with lower arterial blood pressure (BP) and may reduce cardiovascular risk in rheumatoid arthritis (RA). However, it remains unclear whether a cause-and-effect relationship exists between the use of methotrexate and blood pressure reduction.Patients and methods We conducted a controlled comparative study of treatment-naïve newly diagnosed RA patients commenced on subcutaneous methotrexate (Group 1, n = 31, age 57 ± 15 years, 65% females, Disease Activity Score-28 – C-reactive protein, DAS28-CRP = 4.7 ± 1.2) or the DMARD comparator sulfasalazine (Group 2, n = 31, 54 ± 17 years, 61% females, DAS28-CRP = 5.0 ± 0.8). Clinic systolic (SBP, primary study endpoint) and diastolic BP (DBP) and augmentation index (AIx, a marker of arterial stiffness) were measured at baseline and after one and six months of treatment (ClinicalTrials.gov: NCT03254589).Results After six months, compared to Group 2, Group 1 patients had significantly lower SBP (−7.4 mmHg, 95% CI −14.0 to −0.8, p = 0.03). By contrast, there were no significant between-group differences in DBP (p = 0.18), AIx (p = 0.85), or DAS28-CRP (p = 0.16). A significant effect of single nucleotide polymorphisms (SNPs) rs1801133 (methyl tetrahydrofolate reductase) and rs2231142 (ATP-binding cassette subfamily G member 2) on BP changes during methotrexate treatment was observed.Conclusions This is the first comparative study showing that methotrexate significantly reduces SBP in RA. This effect did not coincide with significant changes in arterial stiffness or disease activity. Further research is warranted to investigate the mechanisms underpinning the SBP-lowering effects of methotrexate, the role of specific SNPs, and whether such effects may account for reduced cardiovascular risk in patients with RA.
Identifiers
- OPENALEX
- https://openalex.org/W4412807195
- DOI
- 10.1080/07853890.2025.2539311
- PMID
- https://pubmed.ncbi.nlm.nih.gov/40742006
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12315184
Documentary context
- Documentary family
- article
- Source-reported types
- article
- Publishers
- Informa
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1
Cite this reference
Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. 2025. https://doi.org/10.1080/07853890.2025.2539311
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. (2025). A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. https://doi.org/10.1080/07853890.2025.2539311
- Chicago
- Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. 2025. https://doi.org/10.1080/07853890.2025.2539311
- ISO 690
- Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. 2025. https://doi.org/10.1080/07853890.2025.2539311
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR Global Rights of Nature Legal Library. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-b1124e532cd3733b5ba9578ff074ab7c/ · Last HTTP verification: not performed
Research dossiers and documentary relations
Source roles
Bibliographic / original publication source · https://doi.org/10.1080/07853890.2025.2539311
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.